Lymphocyte-Rich Classical Hodgkin Lymphoma
Also known as: Lymphocyte-Rich Classic Hodgkin Lymphoma / Nodular lymphocyte predominant Hodgkin lymphoma / Lymphocyte-rich Hodgkin lymphoma / Hodgkin's disease, lymphocytic-histiocytic predominance / Hodgkin's disease lymphocyte predominance type stage unspecified / Lymphocyte-Rich Classical Hodgkin's Lymphoma / Hodgkin lymphoma, lymphocyte-rich (disorder) / Hodgkin lymphoma, lymphocyte-rich (morphologic abnormality)
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB02379 | Beta-D-Glucose | 2 | Active Not Recruiting | 1 |
DB00290 | Bleomycin | 2 | Active Not Recruiting | 1 |
DB08870 | Brentuximab vedotin | 2 | Active Not Recruiting | 1 |
DB00958 | Carboplatin | 2 | Active Not Recruiting | 1 |
DB00531 | Cyclophosphamide | 2 | Active Not Recruiting | 1 |
DB00851 | Dacarbazine | 2 | Active Not Recruiting | 2 |
DB00694 | Daunorubicin | 2 | Active Not Recruiting | 1 |
DB00997 | Doxorubicin | 2 | Active Not Recruiting | 2 |
DB00773 | Etoposide | 2 | Active Not Recruiting | 1 |
DB01181 | Ifosfamide | 2 | Active Not Recruiting | 1 |
DB03366 | Imidazole | 2 | Active Not Recruiting | 2 |
DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 2 |
DB00570 | Vinblastine | 2 | Active Not Recruiting | 2 |
DB08870 | Brentuximab vedotin | 3 | Active Not Recruiting | 1 |
DB00851 | Dacarbazine | 3 | Active Not Recruiting | 1 |
DB00997 | Doxorubicin | 3 | Active Not Recruiting | 1 |
DB00099 | Filgrastim | 3 | Active Not Recruiting | 1 |
DB03366 | Imidazole | 3 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 3 | Active Not Recruiting | 1 |
DB00019 | Pegfilgrastim | 3 | Active Not Recruiting | 1 |
DB00570 | Vinblastine | 3 | Active Not Recruiting | 1 |